Showing results (31-40 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|February 6, 2010
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidatesAggeliki Spentzou, Philip Bergin, Dilbinder Gill, et al.
Pharmacogenomics|March 30, 2007
Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trialsAnthony Kebba, Nesrina Imami, Daniel Bugembe-Lule, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Immune reconstitution in HIV-1-infected patientsNesrina Imami, Gareth Hardy, Antonio Pires, et al.
AIDS (London, England)|June 5, 2007
Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patientsGuglielmo Rosignoli, Alison Cranage, Catherine Burton, et al.
AIDS (London, England)|February 25, 2003
Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapyAnn K Sullivan, Gareth A Hardy, Mark R Nelson, et al.
International Journal of Cancer|December 4, 2003
Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Tom Newsom-Davis, et al.
European Journal of Immunology|August 23, 2005
Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: implications for mucosal vaccinesGeorge Rozis, Shamika de Silva, Adel Benlahrech, et al.
Nature Cell Biology|April 27, 2010
miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activatorDimitrios Lagos, Gabriel Pollara, Stephen Henderson, et al.
International Journal of Experimental Pathology|July 2, 2011
Gene expression profiling in male genital lichen sclerosusEmma Edmonds, Geraint Barton, Sandrine Buisson, et al.
AIDS (London, England)|September 10, 2003
Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Ornella Flore, et al.
Pageof 18